Rogliani P - Search Results

1

Synergy across the drugs approved for the treatment of asthma.

Rogliani P, Ritondo BL, Cavalli F, Giorgino FM, Girolami A, Pane G, Pezzuto G, Zerillo B, Puxeddu E, Ora J. Rogliani P, et al. Minerva Med. 2022 Feb;113(1):17-30. doi: 10.23736/S0026-4806.21.07266-9. Epub 2021 Jan 26. Minerva Med. 2022. PMID: 33496162 Free article. Review.

2

HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema.

Rogliani P, Mura M, Mattia P, Ferlosio A, Farinelli G, Mariotta S, Graziano P, Pezzuto G, Ricci A, Saltini C, Orlandi A. Rogliani P, et al. Respir Med. 2008 Dec;102(12):1753-61. doi: 10.1016/j.rmed.2008.07.010. Epub 2008 Aug 23. Respir Med. 2008. PMID: 18723334 Free article.

3

A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD.

Cazzola M, Rogliani P, Curradi G, Segreti A, Ciaprini C, Pezzuto G, Saltini C. Cazzola M, et al. Among authors: rogliani p. Pulm Pharmacol Ther. 2009 Dec;22(6):522-5. doi: 10.1016/j.pupt.2009.05.005. Epub 2009 May 27. Pulm Pharmacol Ther. 2009. PMID: 19481169

4

Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement.

Sergiacomi G, Bolacchi F, Cadioli M, Angeli ML, Fucci F, Crusco S, Rogliani P, Pezzuto G, Romeo F, Mariano E, Simonetti G. Sergiacomi G, et al. Among authors: rogliani p. Radiology. 2010 Feb;254(2):601-8. doi: 10.1148/radiol.09081546. Radiology. 2010. PMID: 20093531 Free article.

5

An update on bronchodilators in Phase I and II clinical trials.

Cazzola M, Rogliani P, Segreti A, Matera MG. Cazzola M, et al. Among authors: rogliani p. Expert Opin Investig Drugs. 2012 Oct;21(10):1489-501. doi: 10.1517/13543784.2012.710602. Epub 2012 Aug 23. Expert Opin Investig Drugs. 2012. PMID: 22916733 Review.

6

Effect of an additional dose of indacaterol in COPD patients under regular treatment with indacaterol.

Cazzola M, Segreti A, Stirpe E, Puxeddu E, Ora J, Rogliani P, Matera MG. Cazzola M, et al. Among authors: rogliani p. Respir Med. 2013 Jan;107(1):107-11. doi: 10.1016/j.rmed.2012.09.022. Epub 2012 Oct 18. Respir Med. 2013. PMID: 23083839 Free article. Clinical Trial.

7

A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD.

Ora J, Calzetta L, Pezzuto G, Senis L, Paone G, Mari A, Portalone S, Rogliani P, Puxeddu E, Saltini C. Ora J, et al. Among authors: rogliani p. Respir Med. 2013 Dec;107(12):2014-21. doi: 10.1016/j.rmed.2013.10.002. Epub 2013 Oct 10. Respir Med. 2013. PMID: 24161677 Free article.

8

Effect of indacaterol on arterial blood gases in patients suffering from acute exacerbation of COPD.

Rogliani P, Ora J, Ciaprini C, Senis L, Stirpe E, Cazzola M. Rogliani P, et al. Respir Med. 2014 Feb;108(2):307-13. doi: 10.1016/j.rmed.2013.10.022. Epub 2013 Nov 5. Respir Med. 2014. PMID: 24238769 Free article. Clinical Trial.

9

Translational Study Searching for Synergy between Glycopyrronium and Indacaterol.

Cazzola M, Calzetta L, Segreti A, Facciolo F, Rogliani P, Matera MG. Cazzola M, et al. Among authors: rogliani p. COPD. 2015 Apr;12(2):175-81. doi: 10.3109/15412555.2014.922172. Epub 2014 Sep 15. COPD. 2015. PMID: 25222881 Free article. Clinical Trial.

10

Canakinumab for the treatment of chronic obstructive pulmonary disease.

Rogliani P, Calzetta L, Ora J, Matera MG. Rogliani P, et al. Pulm Pharmacol Ther. 2015 Apr;31:15-27. doi: 10.1016/j.pupt.2015.01.005. Epub 2015 Feb 4. Pulm Pharmacol Ther. 2015. PMID: 25660162 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters